相似文献/References:
[1]陆显义,王昊珏,周冠琼,等.先兆流产380例保胎治疗后继续妊娠结局分析[J].中国计划生育和妇产科,2009,(06):0.
[2]王本昀,刘洁.血管内皮生长因子、妊娠相关蛋白A联合检测在鉴别诊断先兆流产及异位妊娠中的价值[J].中国计划生育和妇产科,2015,(10):0.
WANG Ben-yun,LIU Jie,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(05):0.
[3]张帆,黄志琨,祝新武,等.联合检测激活素A、抑制素A及CA125在先兆流产预后评估及诊断中的价值[J].中国计划生育和妇产科,2016,(03):0.
ZHANG Fan,HUANG Zhi-kun,ZHU Xin-wu,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(05):0.
[4]刘小燕.地屈孕酮治疗先兆流产剂量与效果的相关性研究[J].中国计划生育和妇产科,2018,(7):90.
LIU Xiao-yan.Study on the correlation between the effect and dose of dydrogesterone in the treatment of threatened abortion[J].Chinese Journal of Family Planning & Gynecotokology,2018,(05):90.
[5]刘新娟,王静,黎东梅,等.孕早期先兆流产危险因素的Logistic回归分析[J].中国计划生育和妇产科,2019,(3):45.
LIU Xin-juan,WANG Jing,LI Dong-mei,et al.Logistic regression analysis of risk factors for threatened abortion in early pregnancy[J].Chinese Journal of Family Planning & Gynecotokology,2019,(05):45.